References
- Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 1999;162:1301–6.
- Emberton M, Anson K. Acute urinary retention in men: an age old problem. BMJ 1999;318:921–5.
- Gray M. Urinary retention. Management in the acute care setting. Part 1. Am J Nurs 2000;100:40–7.
- Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S, Reten-World Study Group. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int 2012;109:88–95.
- Roehrborn CG. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In Wein A, Kavoussi L, Novick A, Partin A, Peters C, editors. Campbell-Walsh urology. 10th edition. Elsevier Saunders; Philadelphia: 2012. p 2570.
- Schulman CC. Long-term aspects of medical treatment of BPH. Eur Urol 2001;40:8–12.
- Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology 2001;58:5–16.
- Kalejaiye O, Speakman MJ. Management of acute and chronic retention in men. Eur Urol Suppl 2009;8:523–9.
- Thomas K, Oades G, Taylor-Hay C, Kirby RS. Acute urinary retention: what is the impact on patients' quality of life? BJU Int 2005;95:72–6.
- Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997;158:481–7.
- Emberton M, Fitzpatrick JM. The Reten-World survey of the management of acute urinary retention: preliminary results. BJU Int 2008;101:27–32.
- Manikandan R, Srirangam SJ, O'Reilly PH, Collins GN. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey. BJU Int 2004;93:84–8.
- Kumar S, Tiwari DP, Ganesamoni R, Singh SK. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention. Urology 2013;82:171–5.
- Lucas MG, Stephenson TP, Nargund V. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int 2005;95:354–7.
- Masumori N, Tsukamoto T, Horita H, Sunaoshi K, Tanaka Y, Takeyama K, et al. α1-Blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5-year outcome analysis of a prospective multicenter study. Int J Urol 2013;20:421–8.
- Williamson ML. Reducing post-catheterization bladder dysfunction by reconditioning. Nurs Res 1982;31:28–30.
- Roe B. Do we need to clamp catheters? Nurs Times 1990;86:66–7.
- Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev 2007:CD004011.
- Moon HJ, Chun MH, Lee SJ, Kim BR. The usefulness of bladder reconditioning before indwelling urethral catheter removal from stroke patients. Am J Phys Med Rehabil 2012;91:681–8.
- Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, Radziszewski P, et al. Guidelines on neurogenic lower urinary tract dysfunction. Eur Assoc Urol 2013; Epub ahead of print.
- Djavan B, Madersbacher S, Klingler C, Marberger M. Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable? J Urol 1997;158:1829–33.
- Izard J, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU Int 2011;108:89–93.
- Saito M, Miyagawa I. Bladder dysfunction after acute urinary retention in rats. J Urol 2001;165:1745–7.
- Batista JE, Wagner JR, Azadzoi KM, Krane RJ, Siroky MB. Direct measurement of blood flow in the human bladder. J Urol 1996;155:630–3.
- Parekh MH, Lobel R, O'Connor LJ, Leggett RE, Levin RM. Protective effect of vitamin E on the response of the rabbit bladder to partial outlet obstruction. J Urol 2001;166:341–6.